Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2025-12-25 @ 8:58 PM
NCT ID: NCT04365556
Description: CCHMC study personnel monitored data collection, progress through treatment, any technical difficulties, adverse events, and completion of study procedures. Any adverse events (i.e., breach of confidentiality or events that are unexpected and related to the intervention) were to be reported to the IRB within 48 hours. All other adverse events that happen in the course of the study procedures in table form at the next yearly continuing IRB review.
Frequency Threshold: 5
Time Frame: 4 years and 7 months
Study: NCT04365556
Study Brief: Using Technology-Assisted Stepped Care Intervention to Improve Adherence in Adolescents With Asthma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
TASC Intervention Step 1 of the intervention includes educational materials related to asthma. Step 2 includes electronic monitoring of adherence and a text messaging intervention personally tailored to the participant. Step 3 includes problem solving telehealth sessions with a trained clinician. TASC Intervention: All participants receive Step 1 of the intervention. Participants who have adherence below or at 68% will step up to Step 2 or Step 3 after the third or fourth month in the study. 0 None 0 37 0 37 View
Treatment as Usual Participants will not receive any intervention. 0 None 0 35 0 35 View
Serious Events(If Any):
Other Events(If Any):